The First Rejection Came in May 2017
Dr Amol Ingule bought an Optima Restore Floater policy from Apollo Munich Health Insurance for his family, effective 21 February 2017 to 20 February 2018. The cover was Rs 20 lakh. On 17 April 2017, his son was admitted to Apollo Hospital in Navi Mumbai with severe abdominal pain and underwent emergency surgery the next day. Ingule sought reimbursement for that admission.
Apollo Munich rejected the claim by email on 27 May, citing non-disclosure of the child's earlier speech delay. Ingule replied on 31 May that the delay was a childhood developmental issue his son had outgrown. The insurer also cancelled the family policy. This sequence matters: the first rejection followed the April hospitalisation; the cancellation then affected the family's protection through the son's subsequent cancer treatment.
The child was diagnosed with Burkitt's lymphoma around April–May 2017 and underwent chemotherapy. Later he developed a fungal brain infection and needed surgery at Tata Memorial Hospital and Apollo Hospital. He died in February 2018. Ingule documented Rs 33,58,794 in treatment expenses. The family's loss deserves a precise account of what the commission decided, without treating the entire expenditure as covered automatically.
The Insurer's Missing Defence
The insurer appeared through counsel in the Maharashtra State Consumer Disputes Redressal Commission, but did not file its written version within the allowed period. The commission recorded a no-written-version order on 13 October 2021. It also noted that the insurer did not submit written notes on legal points despite an opportunity. Ingule placed his affidavit, medical reports, policy, rejection email and itemised bills before the commission.
That procedural history mattered. The commission assessed the doctor's evidence as unchallenged because Apollo Munich neither filed a written defence nor led evidence to rebut it. An account of this judgment that only says the speech-delay ground failed would miss why the particular record before the commission was so one-sided.
Why Childhood Speech Delay Did Not Support This Rejection
In its 2 July 2026 judgment, the commission found that the temporary developmental speech delay relied upon by the insurer was not a chronic disease, pre-existing medical deformity or material fact requiring declaration under the standard health proposal form as it considered this case. It found no medical or pathological connection between that childhood issue and Burkitt's lymphoma or the later fungal infection. The commission described the repudiation and mid-term cancellation as arbitrary and legally untenable, and held the insurer responsible for deficiency in service and unfair trade practice.
These are the commission's findings on Ingule's evidence and the insurer's failure to contest it. They should not be reduced to a blanket rule that no speech or developmental history ever needs disclosure. Another proposal may ask a specific question, and another medical record may contain a diagnosis or treatment that changes the materiality analysis. The wording, answers and chronology must be read together.
Why the Award Was Rs 20 Lakh
The commission accepted documented treatment expenses of Rs 33,58,794 but held that it could not expand an insurance contract beyond its Rs 20 lakh sum insured. It ordered the two Apollo Munich opposite parties, jointly and severally, to pay Rs 20 lakh on the claim, with 9% annual interest from the 27 May 2017 repudiation until payment. It also awarded Rs 20,000 for mental agony and Rs 25,000 in litigation costs.
The order allowed 30 days from receipt of a certified copy for compliance. If payment was not made in that period, interest on the Rs 20 lakh principal was to rise to 10% per year until payment. That conditional increase belongs to this order; it is not a general interest rate for rejected health claims.
The File Questions We Would Ask First
For a comparable dispute, we would put the proposal form beside the rejection and cancellation letters. Did the form ask about a diagnosed condition, treatment, developmental history or a broader category? What was actually disclosed, and what dated records exist from before the policy began? The insurer's specific allegation and policy clause should be identified before anyone assumes that an omitted childhood observation was material.
We would then trace the treatment bills by admission, diagnosis and date, checking what happened before and after cancellation and whether the claimed amounts fit within the actual sum insured and other terms. The April surgery, later lymphoma treatment and fungal infection formed one family's chronology, but the first repudiation and the later total bills are not the same event.
If the reason remains unsupported, the policyholder can submit the proposal, clinical records, claim papers and insurer correspondence to the insurer's grievance officer, then consider Bima Bharosa and an eligible Ombudsman or consumer complaint. Preserving the insurer's response and proof of submission makes the sequence reviewable. A favourable order elsewhere cannot replace the evidence in the claimant's own file.
The Raipur oral-cancer lifestyle-evidence case involved a different medical allegation: the insurer's account of a long-standing disease and habit-related exclusion was not substantiated on that record. Both cases show why the stated ground must be tested against the actual documents.
Where the Mumbai Order Stops
This was a state consumer commission's decision in Dr Amol Ingule v Apollo Munich Health Insurance Co Ltd, Consumer Complaint SC/27/CC/866/2018. Its finding on speech delay was tied to the undisputed evidence, the proposal context and the insurer's failure to file a defence. The contract still limited the medical claim to Rs 20 lakh despite substantially higher bills. A new dispute needs its own proposal, clinical history, cancellation record and policy terms assessed before drawing a conclusion.
